These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31794142)

  • 41. Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Höllriegel R; Spindler A; Kiefer P; Woitek FJ; Leontyev S; Haussig S; Crusius L; Stachel G; Schlotter F; Hommel J; Borger MA; Thiele H; Holzhey D; Linke A; Mangner N
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E196-E203. PubMed ID: 31714684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-Term and Long-Term Outcomes of Patients Undergoing Urgent Transcatheter Aortic Valve Replacement Under a Minimalist Strategy.
    Ichibori Y; Li J; Patel T; Lipinski J; Ladas T; Saric P; Kobe D; Tsushima T; Peters M; Patel S; Davis A; Markowitz AH; Bezerra HG; Costa MA; Kalra A; Attizzani GF
    J Invasive Cardiol; 2019 Feb; 31(2):E30-E36. PubMed ID: 30700628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach.
    Walas RL; Kukulski L; Rychter J; Jaźwiec T; Gąska M; Hawranek M; Zembala M; Gąsior M; Zembala MO
    J Cardiovasc Surg (Torino); 2020 Feb; 61(1):117-122. PubMed ID: 31815374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Zilberszac R; Chandiramani R; Hengstenberg C; Sartori S; Cao D; Chandrasekhar J; Schafer U; Tchetche D; Violini R; Jeger R; Van Belle E; Boekstegers P; Hambrecht R; Tron C; Dumenteil N; Linke A; Ten Berg JM; Deliargyris EN; Anthopoulos P; Mehran R; Dangas G
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E377-E386. PubMed ID: 31808295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.
    Gleason TG; Schindler JT; Hagberg RC; Deeb GM; Adams DH; Conte JV; Zorn GL; Hughes GC; Guo J; Popma JJ; Reardon MJ
    Ann Thorac Surg; 2018 Feb; 105(2):477-483. PubMed ID: 29100645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement.
    Stundl A; Schulte R; Lucht H; Weber M; Sedaghat A; Shamekhi J; Zur B; Grube E; Mellert F; Welz A; Fimmers R; Nickenig G; Werner N; Sinning JM
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1550-1560. PubMed ID: 28797433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Honda Y; Yamawaki M; Araki M; Tada N; Naganuma T; Yamanaka F; Watanabe Y; Yamamoto M; Shirai S; Hayashida K;
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1387-1396. PubMed ID: 29602206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Fernandez-Lopez L; Chevalier B; Lefèvre T; Spaziano M; Unterseeh T; Champagne S; Benamer H; Sanguineti F; Garot P; Hovasse T
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1367-1373. PubMed ID: 30536569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany.
    Frerker C; Bestehorn K; Schlüter M; Bestehorn M; Hamm CW; Möllmann H; Katus HA; Kuck KH
    Clin Res Cardiol; 2017 Aug; 106(8):610-617. PubMed ID: 28283745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement.
    Rymer JA; Xiang Q; Wang A; Cohen DJ; Desai ND; Kirtane AJ; Hughes GC; Harrison JK; Kosinski AS; Vemulapalli S
    JACC Cardiovasc Interv; 2019 Sep; 12(18):1768-1777. PubMed ID: 31473238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
    Baumbach H; Schairer ER; Wachter K; Rustenbach C; Ahad S; Stan A; Hill S; Bramlage P; Franke UFW; Schäufele T
    BMC Cardiovasc Disord; 2019 May; 19(1):108. PubMed ID: 31088373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.
    Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D
    Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and predictors of next-day discharge after elective transfemoral transcatheter aortic valve replacement.
    Rathore S; Latyshev Y; Emore S; Rowe J; Foerst J
    Cardiovasc Revasc Med; 2017 Dec; 18(8):583-587. PubMed ID: 28551423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mid-Term Outcomes after Transapical and Transfemoral Transcatheter Aortic Valve Implantation for Aortic Stenosis and Porcelain Aorta with a Systematic Review of Transfemoral versus Transapical Approach.
    Useini D; Haldenwang P; Schlömicher M; Christ H; Naraghi H; Moustafine V; Strauch J
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):623-632. PubMed ID: 31242522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Transfemoral Versus Transradial Secondary Access in Transcatheter Aortic Valve Replacement.
    Junquera L; Urena M; Latib A; Muñoz-Garcia A; Nombela-Franco L; Faurie B; Veiga-Fernandez G; Alperi A; Serra V; Regueiro A; Fischer Q; Himbert D; Mangieri A; Colombo A; Muñoz-García E; Vera-Urquiza R; Jiménez-Quevedo P; de la Torre JM; Pascual I; Garcia Del Blanco B; Sabaté M; Mohammadi S; Freitas-Ferraz AB; Guimarães L; Couture T; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008609. PubMed ID: 32089002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Koifman E; Magalhaes M; Kiramijyan S; Escarcega RO; Didier R; Torguson R; Ben-Dor I; Corso P; Shults C; Satler L; Pichard A; Waksman R
    Cardiovasc Revasc Med; 2016; 17(5):318-21. PubMed ID: 27394178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.